Aromatase Blockade Is Associated With Increased Mortality in Acute Illness in Male Mice

Abstract

Context:The increase in circulating estrogen levels with acute illness in humans is accompanied by increased aromatase expression in adipose tissue and increased peripheral aromatization of estrogens to androgens. Animal studies indicate that estrogen may be beneficial in acute illness.Objective:We hypothesized that blockade of aromatase in acute illness would decrease survival.Design:Prospective sham controlled.Setting:Maine Medical Center Research Institute animal facility.Animals:Six- to 8-week-old male black 6 mice.Intervention:Mice underwent cecal ligation and puncture (CLP) to induce acute illness and were administered letrozole to block aromatase or saline. Mice undergoing sham surgery with or without letrozole served as controls. Adipose and cardiovascular tissue was harvested for preliminary evaluation of aromatase expression.Main outcome measurements:Survival was the main outcome measurement. Evidence for aromatase expression in tissue samples was assessed using western blot and/or immunohistochemistry.Results:With aromatase blockade, survival in CLP mice was decreased (P = 0.04). The presence of aromatase in adipose tissue was observed by western blot in CLP but not control mice. Similarly, the presence of aromatase was observed in cardiac tissue of CLP but not in control mice.Conclusions:The decreased survival during sepsis with aromatase blockade suggests that this response to acute illness may be important both physiologically and clinically. The preliminary observation of aromatase expression in adipose and cardiovascular tissue during acute illness in this mouse model indicates that this model has parallels to human physiology and may be useful for further studying the aromatase response to acute illness.

Brain Aromatase Modulates Serotonergic Neuron by Regulating Serotonin Levels in Zebrafish Embryos and Larvae

“…Taken together with a recent study showing that GPER in the pituitary of zebrafish embryo regulates heart rate through thyroid hormone ( 78 ), estrogen in brain centrally regulates heart rate through various mechanisms. On the other hand, cardiac functions are directly regulated by estrogen ( 79 ) and aromatase has been detected in the heart tissues such as myocardium in mice ( 80 – 82 ). Therefore, it is possible that AroB MO injection may affect aromatase expression in the heart and locally produced estrogen modulates heart rate.…”